Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Breast Neoplasms 10Neoplasms 4Neoplasm Metastasis 3Triple Negative Breast Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Recurrence 2Head and Neck Neoplasms 2Endometrial Neoplasms 2Uterine Cervical Neoplasms 1Unilateral Breast Neoplasms 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma 1Recurrent Ovarian High Grade Serous Adenocarcinoma 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms, Squamous Cell 1Neoplasms by Site 1Multiple Myeloma 1Meningioma 1Lymphoma, Non-Hodgkin 1Low Grade Serous Ovarian Carcinoma 1Locally Advanced (Inoperable) or Metastatic Breast Cancer 1Liposarcoma 1Leiomyosarcoma 1Hereditary Sensory and Autonomic Neuropathies 1Hemangiosarcoma 1HR+/HER2- Breast Cancer 1Glioma 1

Interventions

Specimen Handling 4Doxorubicin 4pembrolizumab 3Magnetic Resonance Spectroscopy 3Biopsy 3pazopanib 2palbociclib 2Radiotherapy 2Radiation 2Ifosfamide 2talimogene laherparepvec 1selinexor 1ribociclib 1peposertib 1mirdametinib 1liposomal doxorubicin 1cemiplimab 1abemaciclib 1X-Rays 1Surgical Procedures, Operative 1Proton Therapy 1Neoadjuvant Therapy 1Immunoglobulin G 1Histamine H2 Antagonists 1Gemcitabine 1Famotidine 1Everolimus 1Docetaxel 1Angptl4 protein, mouse 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Liposarcoma × abemaciclib × 30 days × Clear all
NCT06498648 2026-05-13

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

National Cancer Institute (NCI)

Phase 1/2 Recruiting
74 enrolled
Sarcoma

Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡